Cited by 2,480Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 242 of the 245 references it cites were found in a registry or an index, and 1 are not checked yet.

Neurodegenerative Tauopathies

Lee, Virginia M-Y, Goedert, Michel, Trojanowski, John Q·2001·Annual Review of Neuroscience

DOI 10.1146/annurev.neuro.24.1.1121

Open this paper in CoChat — free account

Abstract

The defining neuropathological characteristics of Alzheimer's disease are abundant filamentous tau lesions and deposits of fibrillar amyloid beta peptides. Prominent filamentous tau inclusions and brain degeneration in the absence of beta-amyloid deposits are also hallmarks of neurodegenerative tauopathies exemplified by sporadic corticobasal degeneration, progressive supranuclear palsy, and Pick's disease, as well as by hereditary frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Because multiple tau gene mutations are pathogenic for FTDP-17 and tau polymorphisms appear to be genetic risk factors for sporadic progressive supranuclear palsy and corticobasal degeneration, tau abnormalities are linked directly to the etiology and pathogenesis of neurodegenerative disease. Indeed, emerging data support the hypothesis that different tau gene mutations are pathogenic because they impair tau functions, promote tau fibrillization, or perturb tau gene splicing, thereby leading to formation of biochemically and structurally distinct aggregates of tau. Nonetheless, different members of the same kindred often exhibit diverse FTDP-17 syndromes, which suggests that additional genetic or epigenetic factors influence the phenotypic manifestations of neurodegenerative tauopathies. Although these and other hypothetical mechanisms of neurodegenerative tauopathies remain to be tested and validated, transgenic models are increasingly available for this purpose, and they…

Integrity signals

Registry

Crossref · 10.1146/annurev.neuro.24.1.1121

Cites

242 of 243 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Prions
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citation
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop*
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Self-citation

Show all 245 references

Research works printed but not linked: 19

Arrasate M, 1997, Am. J. Pathol., 151, 1115
Brion JP, 1985, Arch. Biol., 95, 229
Feany MB, 1995, Am. J. Pathol., 146, 1388
10.1007/s004010050296 · DOI
10.1128/mcb.9.4.1381 · DOI
Hong M, Trojanowski JQ, Lee VM-Y. 2000.Tau-based neurofibrillary lesions.InNeurodegenerative Dementias, ed. CM Clark, JQ Trojanowski, pp. 161–75. New York: McGraw Hill
10.1007/s004010050140 · DOI
Ksiezak-Reding H, 1994, Am. J. Pathol., 145, 1496
10.1007/s004010050138 · DOI
Pickering-Brown S, 2000, Ann. Neurol., 48, 806, 10.1002/1531-8249(200012)48:6<859::aid-ana6>3.0.co;2-1 · DOI
Rebeiz J, 1967, Trans. Am. Neurol. Assoc., 92, 23
Rep. Work Group Frontotemporal Dementia Pick's Disease. 2001. Clinical and neuropathological diagnosis of frontotemporal dementias.Neurobiol. Aging.In press
Shin RW, 1991, Lab. Invest., 64, 693
Snow AD, 1990, Am. J. Pathol., 137, 1253
10.1002/1531-8249(200012)48:6<939::aid-ana17>3.3.co;2-t · DOI
Trojanowski JQ, 1994, Am. J. Pathol., 144, 449
10.1007/s004010050126 · DOI
Wilhelmsen KC, 1994, Am. J. Hum. Genet., 55, 1159
Wilson DM, 1997, Am. J. Pathol., 150, 2181

Sorted by citations

Items 701–800 of 1,023

Extracellular Tau Oligomers Induce Invasion of Endogenous Tau into the Somatodendritic Compartment and Axonal Transport Dysfunction
Swanson, E., Breckenridge, L., McMahon, L. P., Som, S., McConnell, I., & Bloom, G. S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170168 · Cited by 76
Radial Compression of Microtubules and the Mechanism of Action of Taxol and Associated Proteins
Needleman, D. J., Ojeda-López, M. A., Raviv, U., Ewert, K. K., Miller, H. P., Wilson, L., & Safinya, C. R. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.057679 · Cited by 81
Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD
Robinson, J. L., Yan, N., Caswell, C., Xie, S. X., Suh, E. R., Deerlin, V. M. V., Gibbons, G. S., Irwin, D. J., Grossman, M., Lee, E. B., et al. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz141 · Cited by 78
Self-citation
Expression of tau mRNA and soluble tau isoforms in affected and non‐affected brain areas in Alzheimer's disease
Boutajangout, A., Boom, A., Leroy, K., & Brion, J. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.011 · Cited by 77
The Reeler Mouse: Anatomy of a Mutant
D’Arcangelo, G. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)71016-3 · Cited by 80
Behavioral and neurobiological markers of Alzheimer’s disease in Ts65Dn mice: effects of estrogen
Hunter, C. L., Bimonte‐Nelson, H. A., Nelson, M., Eckman, C. B., & Granholm, A. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.10.010 · Cited by 77
Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)
Probst, G. D., & Xu, Y. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.681302 · Cited by 76
Genetics of Progressive Supranuclear Palsy
Im, S. Y., Kim, Y. E., & Kim, Y. J. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.15033 · Cited by 80
Loss of Endothelial Nitric Oxide Synthase Promotes p25 Generation and Tau Phosphorylation in a Murine Model of Alzheimer’s Disease
Austin, S. A., & Katušić, Z. S. (2016) · Circulation Research · doi:10.1161/circresaha.116.309686 · Cited by 73
Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model
van Olst, L., Verhaege, D., Franssen, M., Kamermans, A., Roucourt, B., Carmans, S., Ytebrouck, E., van der Pol, S. M. A., Wever, D. D., Popovic, M. A., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.01.003 · Cited by 76
Fluent molecular mixing of Tau isoforms in Alzheimer’s disease neurofibrillary tangles
Dregni, A. J., Duan, P., Xu, H. W., Changolkar, L. N., Mammeri, N. E., Lee, V. M. ‐., & Hong, M. (2022) · Nature Communications · doi:10.1038/s41467-022-30585-0 · Cited by 76
Self-citation
Single cell gene expression profiling in Alzheimer’s disease
Ginsberg, S. D., Che, S., Counts, S., & Mufson, E. J. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.05.007 · Cited by 76
Shedding light on protein folding landscapes by single-molecule fluorescence
Banerjee, P. R., & Deniz, A. A. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60311c · Cited by 77
The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes
Lasagna‐Reeves, C. A., Sengupta, U., Castillo‐Carranza, D. L., Gerson, J. E., Guerrero‐Munoz, M. J., Troncoso, J. C., Jackson, G. R., & Kayed, R. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-56 · Cited by 78
Comparison of Common and Disease-Specific Post-translational Modifications of Pathological Tau Associated With a Wide Range of Tauopathies
Kametani, F., Yoshida, M., Matsubara, T., Murayama, S., Saito, Y., Kawakami, I., Onaya, M., Tanaka, H., Kakita, A., Robinson, A., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.581936 · Cited by 74
Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases
Dickson, D. W. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0950-z · Cited by 77
Tau mutants bind tubulin heterodimers with enhanced affinity
Elbaum‐Garfinkle, S., Cobb, G., Compton, J. T., Li, X., & Rhoades, E. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315983111 · Cited by 76
Advances in microfluidics-based experimental methods for neuroscience research
Park, J. W., Kim, H. J., Kang, M. W., & Jeon, N. L. (2013) · Lab on a Chip · doi:10.1039/c2lc41081h · Cited by 77
Conformational basis for asymmetric seeding barrier in filaments of three- and four-repeat tau
Siddiqua, A., Luo, Y., Meyer, V., Swanson, M. A., Yu, X., Wei, G., Zheng, J., Eaton, G. R., Ma, B., Nussinov, R., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303498q · Cited by 75
MICEST: A potential tool for non-invasive detection of molecular changes in Alzheimer's disease
Haris, M., Singh, A. K., Cai, K., Nath, K., Crescenzi, R. L., Kogan, F., Hariharan, H., & Reddy, R. D. (2012) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2012.09.025 · Cited by 81
In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy
Crescenzi, R., DeBrosse, C., Nanga, R. P. R., Reddy, S., Haris, M., Hariharan, H., Iba, M., Lee, V. M. Y., Detre, J. A., Borthakur, A., et al. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.06.067 · Cited by 73
Self-citation
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Duan, Y., Dong, S., Gu, F., Hu, Y., & Zhao, Z. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-24 · Cited by 80
Proteolytic Stress Causes Heat Shock Protein Induction, Tau Ubiquitination, and the Recruitment of Ubiquitin to Tau-Positive Aggregates in Oligodendrocytes in Culture
Goldbaum, O., & Richter‐Landsberg, C. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1307-04.2004 · Cited by 75
Constitutive XBP-1s-mediated activation of the endoplasmic reticulum unfolded protein response protects against pathological tau
Waldherr, S. M., Strovas, T. J., Vadset, T. A., Liachko, N. F., & Kraemer, B. C. (2019) · Nature Communications · doi:10.1038/s41467-019-12070-3 · Cited by 74
The Role of Post-Translational Modifications on the Structure and Function of Tau Protein
Ye, H., Han, Y., Li, P., Su, Z., & Huang, Y. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02002-0 · Cited by 76
Hyperphosphorylation and Aggregation of Tau in Experimental Autoimmune Encephalomyelitis
Schneider, A., Araújo, G. W., Trajković, K., Herrmann, M. M., Merkler, D., Mandelkow, E., Weissert, R., & Simons, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409954200 · Cited by 72
Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models
Reddy, P. H., & McWeeney, S. K. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.014 · Cited by 73
Passive immunotherapy of tauopathy targeting pSer413‐tau: a pilot study in mice
Umeda, T., Eguchi, H., Kunori, Y., Matsumoto, Y., Taniguchi, T., Mori, H., & Tomiyama, T. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.171 · Cited by 74
A new approach to the pharmacological regulation of memory: Sarsasapogenin improves memory by elevating the low muscarinic acetylcholine receptor density in brains of memory-deficit rat models
Hu, Y., Xia, Z., Sun, Q., Orsi, A., & Rees, D. D. (2005) · Brain Research · doi:10.1016/j.brainres.2005.08.019 · Cited by 74
Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy
Bhaskar, K., Hobbs, G. A., Yen, S.-H., & Lee, G. S. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01103.x · Cited by 79
A Novel Mechanism of Spine Damages in Stroke via DAPK1 and Tau
Pei, L., Wang, S., Jin, H., Bi, L., Wei, N., Yan, H., Yang, X., Yao, C., Xu, M., Shu, S., et al. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv096 · Cited by 74
Intrabody applications in neurological disorders: progress and future prospects
Miller, T. W., & Messer, A. C. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.003 · Cited by 77
Rho-kinase ROCK inhibitors reduce oligomeric tau protein
Hamano, T., Shirafuji, N., Yen, S.-H., Yoshida, H., Kanaan, N. M., Hayashi, K., Ikawa, M., Yamamura, O., Fujita, Y., Kuriyama, M., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.009 · Cited by 76
Characterization of tau fibrillization in vitro
Xu, S., Brunden, K. R., Trojanowski, J. Q., & Lee, V. M. ‐. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.06.002 · Cited by 81
Self-citation
Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model
Orejana, L., Barros-Miñones, L., Jordán, J., Puerta, E., & Aguirre, N. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.018 · Cited by 73
CDK5 activator protein p25 preferentially binds and activates GSK3β
Chow, H., Guo, D. S., Zhou, J., Zhang, G.-Y., Li, H., Herrup, K., & Zhang, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402627111 · Cited by 78
Beyond the Signal Sequence: Protein Routing in Health and Disease
Castro-Fernández, C., Maya‐Núñez, G., & Conn, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2004-0010 · Cited by 73
Proteasome Inhibition Stabilizes Tau Inclusions in Oligodendroglial Cells that Occur after Treatment with Okadaic Acid
Goldbaum, O., Oppermann, M., Handschuh, M., Dabir, D. V., Zhang, B., Forman, M. S., Trojanowski, J. Q., Lee, V. M. ‐., & Richter‐Landsberg, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08872.2003 · Cited by 73
Self-citation
Reduction of Detyrosinated Microtubules and Golgi Fragmentation Are Linked to Tau-Induced Degeneration in Astrocytes
Yoshiyama, Y., Zhang, B., Bruce, J., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10662.2003 · Cited by 72
Self-citation
A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration
Iijima-Ando, K., Zhao, L., Gatt, A., Shenton, C., & Iijima, K. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq068 · Cited by 72
Oxidative protein damage and the proteasome
Grimm, S., Höhn, A., & Grune, T. (2010) · Amino Acids · doi:10.1007/s00726-010-0646-8 · Cited by 73
Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
Ni, R., Ji, B., Ono, M., Sahara, N., Zhang, M.-R., Aoki, I., Nordberg, A., Suhara, T., & Higuchi, M. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.201632 · Cited by 72
Cortical Neuronal and Glial Pathology in TgTauP301L Transgenic Mice
Murakami, T., Paitel, E., Kawarabayashi, T., Ikeda, M., Chishti, M. A., Janus, C., Matsubara, E., Sasaki, A., Kawarai, T., Phinney, A. L., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051250 · Cited by 73
Corruption and Spread of Pathogenic Proteins in Neurodegenerative Diseases
Walker, L. C., & LeVine, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.399378 · Cited by 75
Effect of treadmill exercise on PI3K/AKT/mTOR, autophagy, and Tau hyperphosphorylation in the cerebral cortex of NSE/htau23 transgenic mice
Kang, E., & Cho, J.-Y. (2015) · Physical Activity and Nutrition · doi:10.5717/jenb.2015.15090806 · Cited by 77
Molecular Mechanisms in the Pathogenesis of Alzheimer’s disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation
Hasegawa, M. (2016) · Biomolecules · doi:10.3390/biom6020024 · Cited by 75
Frontotemporal Lobar Degeneration: Current Concepts in the Light of Recent Advances
Kumar‐Singh, S., & Broeckhoven, C. V. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00055.x · Cited by 73
In vivo 18 F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms
Jones, D. T., Knopman, D. S., Graff-Radford, J., Syrjanen, J. A., Senjem, M. L., Schwarz, C. G., Dheel, C., Wszolek, Z., Rademakers, R., Kantarci, K., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005117 · Cited by 71
Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model
Kim, Y., Choi, H., Lee, W., Park, H., Kam, T.-I., Hong, S.-H., Nah, J., Jung, S., Shin, B., Lee, H., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.12.006 · Cited by 71
Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices
Shahani, N., Subramaniam, S., Wolf, T., Tackenberg, C., & Brandt, R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4245-05.2006 · Cited by 81
Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Kirola, L., Mukherjee, A., & Mutsuddi, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02934-z · Cited by 79
β-Amyloid triggers ALS-associated TDP-43 pathology in AD models
Herman, A. M., Khandelwal, P. J., Stanczyk, B. B., Rebeck, G. W., & Moussa, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.052 · Cited by 75
Isomerase Pin1 Stimulates Dephosphorylation of Tau Protein at Cyclin-dependent Kinase (Cdk5)-dependent Alzheimer Phosphorylation Sites
Kimura, T., Tsutsumi, K., Taoka, M., Saito, T., Masuda‐Suzukake, M., Ishiguro, K., Plattner, F., Uchida, T., Isobe, T., Hasegawa, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.433326 · Cited by 73
Selective alpha7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3beta and decreases tau phosphorylation in vivo.
Bitner, R., Nikkel, A., Markosyan, S., Otte, S., Puttfarcken, P., & Gopalakrishnan, M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.069 · Cited by 72
Developmental neurotoxic effects of two pesticides: Behavior and neuroprotein studies on endosulfan and cypermethrin
Lee, I., Eriksson, P., Fredriksson, A., Buratovic, S., & Viberg, H. (2015) · Toxicology · doi:10.1016/j.tox.2015.06.010 · Cited by 75
Stabilization of the cyclin‐dependent kinase 5 activator, p35, by paclitaxel decreases β‐amyloid toxicity in cortical neurons
Li, G., Faibushevich, A. A., Turunen, B. J., Yoon, S. O., Georg, G. I., Michaelis, M. L., & Dobrowsky, R. T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01526.x · Cited by 71
Attenuated Neurodegenerative Disease Phenotype in Tau Transgenic Mouse Lacking Neurofilaments
Ishihara, T., Higuchi, M., Zhang, B., Yoshiyama, Y., Hong, M., Trojanowski, J. Q., & Lee, V. M. ‐. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06026.2001 · Cited by 71
Self-citation
Quantitative analysis of tau isoform transcripts in sporadic tauopathies
Connell, J. W., Rodriguez-Martin, T., Gibb, G. M., Kahn, N. M., Grierson, A. J., Hanger, D. P., Revesz, T., Lantos, P. L., Anderton, B. H., & Gallo, J.-M. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.02.014 · Cited by 70
Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer’s disease
Li, H., Ip, S., Yuan, Q., Zheng, G., Tsim, K. W. K., Dong, T. T.-X., Lin, G., Han, Y., Liu, Y., Xian, Y., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.08.194 · Cited by 70
Proteins Recruited to Exosomes by Tau Overexpression Implicate Novel Cellular Mechanisms Linking Tau Secretion with Alzheimer's Disease
Saman, S., Lee, N. C. Y., Inoyo, I. E., Jin, J., Li, Z., Doyle, T., McKee, A. C., & Hall, G. F. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132135 · Cited by 71
Splicing fidelity, enhancers, and disease
Amanda, S. S. (2007) · Frontiers in bioscience · doi:10.2741/2812 · Cited by 70
Alpha‐crystallin expression affects microtubule assembly and prevents their aggregation
Xi, J.-H., Bai, F., McGaha, R., & Andley, U. P. (2006) · The FASEB Journal · doi:10.1096/fj.05-5532com · Cited by 70
Pathologies of axonal transport in neurodegenerative diseases
Liu, X.-A., Rizzo, V., & Puthanveettil, S. V. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0044-7 · Cited by 73
A single neonatal exposure to perfluorohexane sulfonate (PFHxS) affects the levels of important neuroproteins in the developing mouse brain
Lee, I., & Viberg, H. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.05.007 · Cited by 70
Amplification of Tau Fibrils from Minute Quantities of Seeds
Meyer, V., Dinkel, P. D., Hager, E. R., & Margittai, M. (2014) · Biochemistry · doi:10.1021/bi501050g · Cited by 76
Fragmentation of the Golgi Apparatus Induced by the Overexpression of Wild-Type and Mutant Human Tau Forms in Neurons
Liazoghli, D., Perreault, S., Micheva, K. D., Desjardins, M., & Leclerc, N. M. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62366-8 · Cited by 70
SUT-1 enables tau-induced neurotoxicity in C . elegans
Kraemer, B. C., & Schellenberg, G. D. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm143 · Cited by 76
Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies
Sud, R., Geller, E. T., & Schellenberg, G. D. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.30 · Cited by 69
Tau‐4R suppresses proliferation and promotes neuronal differentiation in the hippocampus of tau knockin/ knockout mice
Sennvik, K., Boekhoorn, K., Lasrado, R., Terwel, D., Verhaeghe, S., Korr, H., Schmitz, C., Tomiyama, T., Mori, H., Krugers, H., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7735com · Cited by 66
Interleukin-10 deficiency exacerbates inflammation-induced tau pathology
Weston, L. L., Jiang, S., Chisholm, D., Jantzie, L. L., & Bhaskar, K. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02211-1 · Cited by 69
The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration
Deger, J. M., Gerson, J. E., & Kayed, R. (2015) · Aging Cell · doi:10.1111/acel.12359 · Cited by 69
Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies.
Tramutola, A., Lanzillotta, C., & Di Domenico, F. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1244482 · Cited by 69
UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation
Subramanian, M., Hyeon, S. J., Das, T., Suh, Y. S., Kim, Y. K., Lee, J.-S., Song, E. J., Ryu, H., & Yu, K. (2021) · Nature Communications · doi:10.1038/s41467-021-23597-9 · Cited by 62
Tau Protein Assembles into Isoform- and Disulfide-dependent Polymorphic Fibrils with Distinct Structural Properties
Furukawa, Y., Kaneko, K., & Nukina, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248963 · Cited by 73
In vivo measurement of plaque burden in a mouse model of Alzheimer's disease
Borthakur, A., Gur, T., Wheaton, A. J., Corbo, M. T., Trojanowski, J. Q., Lee, V. M. ‐., & Reddy, R. D. (2006) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20751 · Cited by 69
Self-citation
Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease
Ando, K., Tomimura, K., Sazdovitch, V., Suain, V., Yilmaz, Z., Authelet, M., Ndjim, M., Vergara, C., Belkouch, M., Potier, M., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.017 · Cited by 71
In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510
Ishikawa, A., Tokunaga, M., Maeda, J., Minamihisamatsu, T., Shimojo, M., Takuwa, H., Ono, M., Ni, R., Hirano, S., Kuwabara, S., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170509 · Cited by 69
A Drosophila Model of Alzheimer's Disease
Crowther, D. C., Page, R., Chandraratna, D., & Lomas, D. A. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)12015-7 · Cited by 55
Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer’s disease
Sen, T., Saha, P., Jiang, T., & Sen, N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916895117 · Cited by 68
Bassoon contributes to tau-seed propagation and neurotoxicity
Martinez, P., Patel, H., You, Y., Jury, N., Perkins, A., Lee-Gosselin, A., Taylor, X., You, Y., Viana Di Prisco, G., Huang, X., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01191-6 · Cited by 68
What can biomarkers tell us about cognition in Parkinson's disease?
Mollenhauer, B., Rochester, L., Chen‐Plotkin, A. S., & Brooks, D. J. (2014) · Movement Disorders · doi:10.1002/mds.25846 · Cited by 69
Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease
Laws, S. M., Friedrich, P., Diehl‐Schmid, J., Müller, J., Eisele, T., Bäuml, J., Förstl, H., Kurz, A., & Riemenschneider, M. J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001935 · Cited by 68
Prostate-derived Sterile 20-like Kinases (PSKs/TAOKs) Phosphorylate Tau Protein and Are Activated in Tangle-bearing Neurons in Alzheimer Disease
Tavares, I. A., Touma, D., Lynham, S., Troakes, C., Schober, M. S., Čaušević, M., Garg, R., Noble, W. J., Killick, R., Bódi, I., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.448183 · Cited by 69
Abnormal processing of tau in the brain of aged TgCRND8 mice
Bellucci, A., Rosi, M. C., Grossi, C., Fiorentini, A., Luccarini, I., & Casamenti, F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.008 · Cited by 68
Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer’s disease pathogenesis: Potential strategies to protect the LC against aging
Satoh, A., & Iijima, K. (2017) · Brain Research · doi:10.1016/j.brainres.2017.12.027 · Cited by 72
Alzheimer’s Disease – Future Therapy Based on Dendrimers
Aliev, G., Ashraf, G. M., Tarasov, V. V., Chubarev, V. N., Leszek, J., Gąsiorowski, K., Makhmutovа, A., Baeesa, S. S., Ávila-Rodriguez, M., Ustyugov, A. A., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180918164623 · Cited by 70
Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease
Vandrovcová, J., Pittman, A. M., Malzer, E., Abou‐Sleiman, P. M., Lees, A. J., Wood, N. W., & de Silva, R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.019 · Cited by 67
Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's disease
Ofori, E., DeKosky, S. T., Febo, M., Colón-Pérez, L. M., Chakrabarty, P., Duara, R., Adjouadi, M., Golde, T. E., & Vaillancourt, D. E. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101985 · Cited by 64
Proliferation of Tau 304–380 Fragment Aggregates through Autocatalytic Secondary Nucleation
Camargo, D. C. R., Šileikis, E., Chia, S., Axell, E., Bernfur, K., Cataldi, R., Cohen, S. I. A., Meisl, G., Habchi, J., Knowles, T. P. J., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00454 · Cited by 64
Increased association between rough endoplasmic reticulum membranes and mitochondria in transgenic mice that express P301L tau
Perreault, S., Bousquet, O., Lauzon, M., Paiement, J., & Leclerc, N. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a1fc49 · Cited by 67
Tau gene (MAPT) sequence variation among primates
Holzer, M., Craxton, M., Jakes, R., Arendt, T., & Goedert, M. (2004) · Gene · doi:10.1016/j.gene.2004.07.013 · Cited by 67
Self-citation
Tau interacts with Golgi membranes and mediates their association with microtubules
Farah, C. A., Perreault, S., Liazoghli, D., Desjardins, M., Antón, A., Lauzon, M., Paiement, J. M., & Leclerc, N. M. (2006) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20157 · Cited by 73
Pinning down phosphorylated tau and tauopathies
Lim, J., & Lu, K. P. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.10.003 · Cited by 67
The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties
Matsumoto, S.-E., Motoi, Y., Ishiguro, K., Tabira, T., Kametani, F., Hasegawa, M., & Hattori, N. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv351 · Cited by 66
Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions
Villemagne, V. L., & Okamura, N. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.09.002 · Cited by 70
Advances in the development of tau PET radiotracers and their clinical applications
Okamura, N., Harada, R., Furukawa, K., Furumoto, S., Tago, T., Yanai, K., Arai, H., & Kudo, Y. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2015.12.010 · Cited by 68
Prion-like mechanisms in Alzheimer disease
Walker, L. C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00016-7 · Cited by 67
The Slow Axonal Transport of the Microtubule-Associated Protein Tau and the Transport Rates of Different Isoforms and Mutants in Cultured Neurons
Utton, M. A., Connell, J. W., Asuni, A. A., van Slegtenhorst, M., Hutton, M. L., de Silva, R., Lees, A. J., Miller, C. C. J., & Anderton, B. H. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06394.2002 · Cited by 66
Alzheimer’s Disease Pathologic Cascades: Who Comes First, What Drives What
Swerdlow, R. H. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9272-9 · Cited by 69
Virgin coconut oil (VCO) by normalizing NLRP3 inflammasome showed potential neuroprotective effects in Amyloid-β induced toxicity and high-fat diet fed rat
Mirzaei, F., Khazaei, M., Komaki‬, A., Amiri, I., & Jalili, C. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.04.064 · Cited by 70

Authors: Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q.
Affiliations: MRC Laboratory of Molecular Biology (GB)
ORCID: Lee, Virginia M-Y
Goedert, Michel
Trojanowski, John Q
Venue: Annual Review of Neuroscience
Publisher: Annual Reviews
Published: 2001-03
Volume: 24
Issue: 1
Pages: 1121-1159
ISSN: 0147-006X (ISSN-L)
1545-4126
DOI: 10.1146/annurev.neuro.24.1.1121
OpenAlex: W4230565756
Semantic Scholar: 8eb6355272daf41b8da72a5b18a4d8c67d8509cc
Cited by: 2,480
References: 245
Citations by year: 2026: 60 · 2025: 81 · 2024: 102 · 2023: 112 · 2022: 133 · 2021: 130 · 2020: 126 · 2019: 107 · 2018: 114 · 2017: 94 · 2016: 100 · 2015: 115 · 2014: 99 · 2013: 100 · 2012: 92
FWCI: 9.22
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Neuroscience (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: tau protein, tau gene mutations, FTDP-17, progressive supranuclear palsy, corticobasal degeneration, Pick's disease, Alzheimer's disease, tau fibrillization, genetic risk factors, transgenic animal models, neurodegeneration
MeSH terms: Animals, Brain, Brain Diseases, Dementia, Humans, Neurofibrillary Tangles, tau Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neurodegenerative Tauopathies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks